SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (415)4/11/2001 11:13:40 AM
From: nigel bates  Read Replies (1) | Respond to of 2243
 
It's not lockup, but can MCDE really be worth less than $40m ?

nig



To: scaram(o)uche who wrote (415)4/11/2001 12:00:17 PM
From: tuck  Read Replies (1) | Respond to of 2243
 
Rick,

Not the judge of science that you are, but following companies with lock-up blues a lot these days. Faves are AMEV, DPII, RSTA, BDAL. Also plausible are ILMN, DGEN, GNSC, GMNI, GCOR. Mom has eensy position in AMEV.

Why is Monday/Tuesday (I gather you mean next week) so important for scalping?

Cheers, Tuck



To: scaram(o)uche who wrote (415)4/11/2001 12:43:07 PM
From: dalroi  Respond to of 2243
 
perhaps CAMH at these prices

cheers

Stefaan



To: scaram(o)uche who wrote (415)4/14/2001 9:32:27 AM
From: Spekulatius  Read Replies (1) | Respond to of 2243
 
>>If anyone has spotted some good science, available cheap, please speck up!<<
What about DCGN? Valuation seems low and scientific progress very reasonable plus a good cash position. I am a bit cautious because of the dependency from Roche but at this price?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News